{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:19:34Z","timestamp":1792718374826,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03650-3","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:40:39Z","timestamp":1739000439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Risk factors for Clostridioides difficile infection among patients diagnosed with inflammatory intestinal and rheumatological diseases in the biologic era"],"prefix":"10.1186","volume":"25","author":[{"given":"Helena","family":"Mart\u00ednez-Lozano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Saralegui-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Reigadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Ram\u00f3n","family":"Fueyo-Pel\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurea","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Miranda-Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Alcal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena","family":"Lobato-Matilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mar\u00edn-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mench\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"3650_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.medcli.2017.01.033","volume":"148","author":"L Alcala Hernandez","year":"2017","unstructured":"Alcala Hernandez L, Reigadas Ramirez E, Bouza Santiago E. Clostridium difficile infection. Med Clin (Barc). 2017;148:456\u201363.","journal-title":"Med Clin (Barc)"},{"key":"3650_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1086\/502023","volume":"23","author":"MA Miller","year":"2002","unstructured":"Miller MA, Hyland M, Ofner-Agostini M, et al. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol. 2002;23:137\u201340.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3650_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3949\/ccjm.87gr.20001","volume":"87","author":"C Tsigrelis","year":"2020","unstructured":"Tsigrelis C. Recurrent Clostridioides difficile infection: Recognition, management, prevention. Cleve Clin J Med. 2020;87:347\u201359.","journal-title":"Cleve Clin J Med"},{"key":"3650_CR4","doi-asserted-by":"crossref","unstructured":"Boeriu A, Roman A, Fofiu C et al. The current knowledge on Clostridioides difficile infection in patients with inflammatory Bowel diseases. Pathogens 2022;11.","DOI":"10.3390\/pathogens11070819"},{"key":"3650_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1053\/j.gastro.2017.04.044","volume":"153","author":"H Singh","year":"2017","unstructured":"Singh H, Nugent Z, Yu BN, et al. Higher incidence of Clostridium difficile infection among individuals with inflammatory bowel disease. Gastroenterology. 2017;153:430\u20138. e2.","journal-title":"Gastroenterology"},{"key":"3650_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/00365521.2022.2121175","volume":"58","author":"B Gros","year":"2023","unstructured":"Gros B, Soto P, Causse M, et al. Impact of Clostridioides difficile infection in patients admitted with ulcerative colitis. Scand J Gastroenterol. 2023;58:232\u20139.","journal-title":"Scand J Gastroenterol"},{"key":"3650_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cgh.2016.10.024","volume":"15","author":"S Khanna","year":"2017","unstructured":"Khanna S, Shin A, Kelly CP. Management of Clostridium difficile infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute. Clin Gastroenterol Hepatol. 2017;15:166\u201374.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3650_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cgh.2006.12.028","volume":"5","author":"M Issa","year":"2007","unstructured":"Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345\u201351.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3650_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/ecco-jcc\/jjy143","volume":"13","author":"B Balram","year":"2019","unstructured":"Balram B, Battat R, Al-Khoury A, et al. Risk factors Associated with Clostridium difficile infection in inflammatory bowel disease: a systematic review and Meta-analysis. J Crohns Colitis. 2019;13:27\u201338.","journal-title":"J Crohns Colitis"},{"key":"3650_CR10","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.3346\/jkms.2023.38.e359","volume":"38","author":"EM Song","year":"2023","unstructured":"Song EM, Choi A, Kim S, et al. The prevalence and risk factors of Clostridioides difficile infection in inflammatory bowel disease: 10-Year South Korean experience based on the National Database. J Korean Med Sci. 2023;38:e359.","journal-title":"J Korean Med Sci"},{"key":"3650_CR11","doi-asserted-by":"publisher","first-page":"29791","DOI":"10.1038\/srep29791","volume":"6","author":"T Zhang","year":"2016","unstructured":"Zhang T, Lin QY, Fei JX, et al. Clostridium Difficile infection worsen outcome of hospitalized patients with inflammatory bowel disease. Sci Rep. 2016;6:29791.","journal-title":"Sci Rep"},{"key":"3650_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2036.2009.04037.x","volume":"30","author":"S Schneeweiss","year":"2009","unstructured":"Schneeweiss S, Korzenik J, Solomon DH, et al. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther. 2009;30:253\u201364.","journal-title":"Aliment Pharmacol Ther"},{"key":"3650_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.crohns.2011.09.005","volume":"6","author":"U Navaneethan","year":"2012","unstructured":"Navaneethan U, Mukewar S, Venkatesh PG, et al. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. J Crohns Colitis. 2012;6:330\u20136.","journal-title":"J Crohns Colitis"},{"key":"3650_CR14","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.dld.2014.09.003","volume":"46","author":"H Regnault","year":"2014","unstructured":"Regnault H, Bourrier A, Lalande V, et al. Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment. Dig Liver Dis. 2014;46:1086\u201392.","journal-title":"Dig Liver Dis"},{"key":"3650_CR15","first-page":"4","volume":"107","author":"A Ramos-Martinez","year":"2015","unstructured":"Ramos-Martinez A, Ortiz-Balbuena J, Curto-Garcia I, et al. Risk factors for Clostridium difficile diarrhea in patients with inflammatory bowel disease. Rev Esp Enferm Dig. 2015;107:4\u20138.","journal-title":"Rev Esp Enferm Dig"},{"key":"3650_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.crohns.2010.09.007","volume":"5","author":"R Kariv","year":"2011","unstructured":"Kariv R, Navaneethan U, Venkatesh PG, et al. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis. 2011;5:34\u201340.","journal-title":"J Crohns Colitis"},{"key":"3650_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1086\/511798","volume":"28","author":"LC McDonald","year":"2007","unstructured":"McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28:140\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3650_CR18","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","volume":"73","author":"S Johnson","year":"2021","unstructured":"Johnson S, Lavergne V, Skinner AM, et al. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021;73:e1029\u201344.","journal-title":"Clin Infect Dis"},{"key":"3650_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cgh.2006.12.027","volume":"5","author":"JF Rodemann","year":"2007","unstructured":"Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339\u201344.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3650_CR20","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ajg.2016.187","volume":"111","author":"R Razik","year":"2016","unstructured":"Razik R, Rumman A, Bahreini Z, et al. Recurrence of Clostridium difficile infection in patients with inflammatory bowel disease: the RECIDIVISM Study. Am J Gastroenterol. 2016;111:1141\u20136.","journal-title":"Am J Gastroenterol"},{"key":"3650_CR21","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres J, Mehandru S, Colombel JF, et al. Crohn\u2019s disease. Lancet. 2017;389:1741\u201355.","journal-title":"Lancet"},{"key":"3650_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","volume":"66","author":"V Pascal","year":"2017","unstructured":"Pascal V, Pozuelo M, Borruel N, et al. A microbial signature for Crohn\u2019s disease. Gut. 2017;66:813\u201322.","journal-title":"Gut"},{"key":"3650_CR23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/MIB.0000000000000271","volume":"21","author":"EK Wright","year":"2015","unstructured":"Wright EK, Kamm MA, Teo SM, et al. Recent advances in characterizing the gastrointestinal microbiome in Crohn\u2019s disease: a systematic review. Inflamm Bowel Dis. 2015;21:1219\u201328.","journal-title":"Inflamm Bowel Dis"},{"key":"3650_CR24","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3748\/wjg.v20.i5.1165","volume":"20","author":"L Antoni","year":"2014","unstructured":"Antoni L, Nuding S, Wehkamp J, et al. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol. 2014;20:1165\u201379.","journal-title":"World J Gastroenterol"},{"key":"3650_CR25","doi-asserted-by":"publisher","first-page":"101736","DOI":"10.1016\/j.jsps.2023.101736","volume":"31","author":"A Saad Alshahrani","year":"2023","unstructured":"Saad Alshahrani A, Mohammad D, Attieh Alzahrani M, et al. Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: a retrospective cohort study. Saudi Pharm J. 2023;31:101736.","journal-title":"Saudi Pharm J"},{"key":"3650_CR26","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/ibd\/izaa236","volume":"27","author":"WJ Sandborn","year":"2021","unstructured":"Sandborn WJ, Feagan BG, Danese S, et al. Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of results from phase 2\/3 studies. Inflamm Bowel Dis. 2021;27:994\u20131007.","journal-title":"Inflamm Bowel Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03650-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03650-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03650-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:40:46Z","timestamp":1739000446000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03650-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3650"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03650-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved, and the need for consent to participate was waived by the local Clinical Research Ethics Committee of the \u201cHospital General Universitario Gregorio Mara\u00f1\u00f3n\u201d. It was carried out in accordance with the ethical Declaration of Helsinki in 1964.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}